Therapeutic Areas

At Boehringer Ingelheim, we have a 125-year track record of discovery, development, and commercialization of important therapies that make patients’ lives better. Our portfolio is diverse and expanding, maximizing value across therapeutic categories and offering hope for some of the most challenging diseases.

Today, we concentrate our research efforts and investments in these key therapeutic areas:

Transforming the Landscape of Medical Therapy
CardioMetabolic

Learn how we’re setting the bar high for innovation in cardiometabolic diseases.

Learn More
Central Nervous System (CNS)

Learn why new treatment options for CNS diseases is a key priority for Boehringer Ingelheim.

Learn More
Oncology & Cancer Immunology

Discover how we’re partnering with the oncology community to provide new hope for patients with cancer.

Learn More
Biosimilars

Learn about the innovative ways we’re exploring biosimilars to expand overall treatment options to improve the lives of patients and contribute to the quality and sustainability of the US healthcare system.

Learn More
Immunology & Respiratory

Find out how our Immunology and Respiratory discovery research therapeutic area combines our long-standing leadership in respiratory diseases with the proven ability to address unmet needs in immune-mediated diseases.

Learn More